Page last updated: 2024-08-21

oxazoles and Black Fever

oxazoles has been researched along with Black Fever in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Coelho, F; Ferreira, LLG; Teles, HR; Valli, M1
Ballard, J; Be, C; Berman, A; Biggart, A; Bursulaya, B; Caridha, D; Chen, YL; Chianelli, D; Davis, LC; Eggimann, FK; Gao, MY; Gibney, M; Glynne, RJ; Groessl, T; Hein, A; Jiricek, J; Johnson, K; Khare, S; Kreishman-Deitrick, M; Lai, YH; Lerario, I; Liang, F; Liu, X; Luneau, A; Mathison, CJN; Molteni, V; Nagle, A; Pybus, B; Rao, SPS; Richmond, W; Rudewicz, PJ; Sciotti, RJ; Shapiro, M; Smith, J; Spraggon, G; Srinivas, H; Supek, F; Thompson, C; Tuntland, T; Wiesmann, C; Xie, Y; Yeh, V1
Auer, JL; Fairlamb, AH; Norval, S; Osuna-Cabello, M; Patterson, S; Read, KD; Simeons, FR; Stojanovski, L; Wyllie, S1
Bhaduri, A; Mukherjee, T; Roy, K1

Other Studies

4 other study(ies) available for oxazoles and Black Fever

ArticleYear
Hierarchical Clustering and Target-Independent QSAR for Antileishmanial Oxazole and Oxadiazole Derivatives.
    International journal of molecular sciences, 2022, Aug-10, Volume: 23, Issue:16

    Topics: Antiprotozoal Agents; Cluster Analysis; Humans; Leishmaniasis, Visceral; Oxadiazoles; Oxazoles; Quantitative Structure-Activity Relationship

2022
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases.
    Journal of medicinal chemistry, 2020, 10-08, Volume: 63, Issue:19

    Topics: Animals; Antiprotozoal Agents; Dogs; Humans; Leishmania donovani; Leishmania major; Leishmaniasis, Visceral; Liver; Macaca fascicularis; Mice; Mice, Inbred BALB C; Oxazoles; Proteasome Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Triazoles

2020
The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis.
    eLife, 2016, 05-24, Volume: 5

    Topics: Administration, Oral; Animals; Antiprotozoal Agents; Antitubercular Agents; Biotransformation; Disease Models, Animal; Drug Administration Schedule; Drug Dosage Calculations; Drug Repositioning; Female; Hormesis; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Nitroimidazoles; Oxazoles; Parasitic Sensitivity Tests; Treatment Outcome

2016
Acivicin: a highly active potential chemotherapeutic agent against visceral leishmaniasis.
    Biochemical and biophysical research communications, 1990, Jul-31, Volume: 170, Issue:2

    Topics: Animals; Antiprotozoal Agents; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Cells, Cultured; Enzyme Activation; Isoxazoles; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Oxazoles

1990